Heartland Advisors Inc. Grows Position in Teleflex Incorporated $TFX

Heartland Advisors Inc. raised its holdings in Teleflex Incorporated (NYSE:TFX) by 200.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 150,000 shares of the medical technology company’s stock after purchasing an additional 100,000 shares during the quarter. Teleflex comprises approximately 1.0% of Heartland Advisors Inc.’s portfolio, making the stock its 21st largest holding. Heartland Advisors Inc. owned about 0.34% of Teleflex worth $18,354,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its stake in shares of Teleflex by 57.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the last quarter. Hantz Financial Services Inc. lifted its holdings in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Teleflex during the third quarter worth $35,000. True Wealth Design LLC grew its position in Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after buying an additional 310 shares during the last quarter. Finally, Quent Capital LLC acquired a new position in Teleflex in the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX opened at $103.78 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $180.58. The company has a 50-day moving average of $113.64 and a 200-day moving average of $118.88. The company has a market capitalization of $4.59 billion, a P/E ratio of -14.12, a PEG ratio of 1.35 and a beta of 0.92.

Analyst Ratings Changes

Several research firms recently issued reports on TFX. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Wells Fargo & Company cut their price target on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating for the company in a report on Thursday, January 29th. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Truist Financial increased their target price on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 price target on shares of Teleflex in a research note on Wednesday, December 17th. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $139.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.